Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rise » significant risk (Expand Search), significant risks (Expand Search), significant role (Expand Search)
rise decrease » rate decreased (Expand Search), sizes decrease (Expand Search), use decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rise » significant risk (Expand Search), significant risks (Expand Search), significant role (Expand Search)
rise decrease » rate decreased (Expand Search), sizes decrease (Expand Search), use decreased (Expand Search)
-
3621
-
3622
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
3623
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3624
-
3625
-
3626
-
3627
-
3628
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3629
-
3630
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3631
-
3632
-
3633
-
3634
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3635
-
3636
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3637
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3638
-
3639
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3640
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: